SCHEMBL31106070

SCHEMBL31106070

Cc1ccc2c(cnn2C2CCCCO2)c1NC(=O)c1sc(Cl)nc1C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LCK P06239 2/20 0.43
▸ KMT2A Q03164 6/20 0.41
▸ L3MBTL1 Q9Y468 2/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ RXRA P19793 1/20 0.40
▸ RXRB P28702 1/20 0.40
▸ RXRG P48443 1/20 0.40
▸ RAB9A P51151 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ CASP3 P42574 1/20 0.39
▸ SENP8 Q96LD8 1/20 0.39
▸ SENP7 Q9BQF6 1/20 0.39
▸ SENP6 Q9GZR1 1/20 0.39
▸ AHR P35869 1/20 0.39
▸ PKM P14618 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ NPC1 O15118 1/20 0.37
▸ CYP4F2 P78329 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27227895 0.82 RXRA (0.47) KMT2ARXRARXRBRXRGPOLB
SCHEMBL31430725 0.82 RXRA (0.42) LCKSMN1; SMN2RXRARXRBRXRG
SCHEMBL31430803 0.82 RXRA (0.40) RXRARXRBRXRGPOLBCYP4F2
SCHEMBL31105893 0.81 LCK (0.41) LCKRXRARXRBRXRGCYP4F2
SCHEMBL31737727 0.81 RXRA (0.39) LCKRXRARXRBRXRGCYP4F2
SCHEMBL31738052 0.78 RXRA (0.37) LCKRXRARXRBRXRGPOLB
SCHEMBL31105912 0.77 MAPK14 (0.50) LCKRXRARXRBRXRGCYP4F2
SCHEMBL25787278 0.77 CYP4F2 (0.43) KMT2ARXRARXRBRXRGMEN1
SCHEMBL30860912 0.76 RXRA (0.41) LCKRXRARXRBRXRGCYP4F2
SCHEMBL31705188 0.76 LCK (0.52) LCKSMN1; SMN2RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024184520-A1 BIARYLAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF PROLIFERATIVE DISORDERS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-09-12 — — WO disclosed
Send feedback